|
Volumn 10, Issue 3, 2000, Pages 237-241
|
The value of serum S-100β and interleukins as tumour markers in advanced melanoma
a a a a a a a |
Author keywords
Interleukins; Metastatic melanoma; Prognosis; S 100; Tumour markers
|
Indexed keywords
ALPHA INTERFERON;
BLEOMYCIN;
DACARBAZINE;
INTERLEUKIN 10;
INTERLEUKIN 12;
INTERLEUKIN 6;
INTERLEUKIN DERIVATIVE;
LOMUSTINE;
PROTEIN S 100;
RECOMBINANT ALPHA2B INTERFERON;
TUMOR MARKER;
VINCRISTINE;
ADULT;
AGED;
ARTICLE;
BONE METASTASIS;
CANCER CHEMOTHERAPY;
CANCER IMMUNOTHERAPY;
CANCER STAGING;
CANCER SURVIVAL;
CLINICAL ARTICLE;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
FEMALE;
FOLLOW UP;
HUMAN;
HUMAN TISSUE;
LIVER METASTASIS;
MALE;
MELANOMA;
METASTASIS POTENTIAL;
PRIORITY JOURNAL;
PROGNOSIS;
PROTEIN BLOOD LEVEL;
TREATMENT OUTCOME;
|
EID: 0033774323
PISSN: 09608931
EISSN: None
Source Type: Journal
DOI: 10.1097/00008390-200010030-00005 Document Type: Article |
Times cited : (18)
|
References (25)
|